Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Introduced a top-level Locations section with California and Maryland subsections, replacing the prior California Locations and Maryland Locations headings. This clarifies where recruitment sites are listed for the study.
    Difference
    0.3%
    Check dated 2025-12-23T21:20:31.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Study contact details such as the email address (GIClinicaltrials@jhmi.edu), phone number, and contact person name were removed from the Study Details page. The update history shows new dated entries for 2025-12-01 and 2025-12-05.
    Difference
    0.9%
    Check dated 2025-12-09T17:22:25.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:06.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The general government-funding notice about potential delays and operating status, including references to cc.nih.gov and opm.gov, was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:24:47.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The changes appear to be minor, such as layout adjustments and timestamp updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:53:35.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    The page has updated its timeline to include newer date entries (2025-10-08, 2026-10, 2025-10-02) and a new marker “Last Update Posted (Estimated)”, and removed older timestamps (2024-10-23, 2024-10-21, and a generic “Last Update Posted” plus 2024-10). Additionally, it adds a statement about the product being manufactured in and exported from the U.S. No.
    Difference
    1%
    Check dated 2025-10-13T11:56:43.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.